{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:36:58Z","timestamp":1786649818388,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:sec>\n                    <jats:title>Aims and Objectives:<\/jats:title>\n                    <jats:p>This study aims to study the effect of geometric- and patient-related variables in achieving the desired dose-volume constraints to parotid for patients undergoing definitive\/adjuvant intensity-modulated radiotherapy (IMRT) for head and neck squamous cell carcinomas (HNSCC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and Methods:<\/jats:title>\n                    <jats:p>This retrospective study considered HNSCC patients who underwent IMRT at our center between 2009 and 2014. Patients' details and dose-volume parameters were collected, and correlated with dose to parotids using Pearson's correlation test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Sixty-seven patients were found to be eligible. Oral primary predominated (37.3%) and 53 (79%) had locally advanced disease. The parotid volume (PV) had no impact on mean dose. There was a negative linear correlation between the ratio (Parotid-planning target volume [PTV] overlap)\/PV and mean dose to the whole parotid (y = 1.14-0.011\u00d7; R2 = 0.509;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001), suggesting that a ratio of 0.7 resulted in mean dose \u2265 40 Gy and potentially irreversible xerostomia. No association was found between site of primary and parotid dose, but node-positive (N+) patients received significantly higher dose compared to N0 patients (34.5 Gy vs. 29.5 Gy;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001). N + patients persisted to receive higher dose even when T stage was accounted for (32.5 Gy vs. 28.9 Gy for &lt;\/= T2, 35.4 Gy vs. 30.1 Gy for &gt; T2;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.003). On the last follow-up, 35 patients (52%) had &gt;\/=Grade II xerostomia. Average mean dose to combined PV was higher in patients with &gt; grade I xerostomia compared to patients with &lt;\/=Grade I (35 Gy vs. 29 Gy;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The degree of PTV overlap with parotid (\u226530%) and N + disease are the strongest predictors of poor parotid sparing by IMRT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_362_16","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T08:17:06Z","timestamp":1524817026000},"page":"1220-1224","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["A study on the impact of patient-related parameters in the ability to spare parotid glands by intensity-modulated radiotherapy for head and neck squamous cell carcinomas"],"prefix":"10.4103","volume":"14","author":[{"given":"Bhanu Prakash","family":"Bandlamudi","sequence":"first","affiliation":[{"name":"Department of Radiotherapy and Oncology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Sharan","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Oncology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prahlad Hiremagalur","family":"Yathiraj","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Oncology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshul","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Oncology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"Reddy","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Oncology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald Jerard","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Oncology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidyasagar Mamidipudi","family":"Srinivasa","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Oncology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,11,28]]},"reference":[{"key":"R1-20260109","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0360-3016(94)90104-X","article-title":"Quality of life in patients treated for head and neck cancer: A follow-up study 7 to 11 years after radiotherapy","volume":"28","author":"Bjordal","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R2-20260109","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/(SICI)1097-0347(199705)19:3<169::AID-HED1>3.0.CO;2-0","article-title":"Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue","volume":"19","author":"Harrison","year":"1997","journal-title":"Head Neck"},{"key":"R3-20260109","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.clon.2012.05.006","article-title":"Intensity-modulated radiotherapy in the treatment of head and neck cancer","volume":"24","author":"O'Sullivan","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R4-20260109","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"key":"R5-20260109","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.ijrobp.2009.06.090","article-title":"Radiotherapy dose-volume effects on salivary gland function","volume":"76","author":"Deasy","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-20260109","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ijrobp.2007.01.030","article-title":"Spatial and dosimetric variability of organs at risk in head-and-neck intensity-modulated radiotherapy","volume":"68","author":"Robar","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R8-20260109","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijrobp.2006.05.028","article-title":"Geometric factors influencing dosimetric sparing of the parotid glands using IMRT","volume":"66","author":"Hunt","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-20260109","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0360-3016(03)01391-9","article-title":"Level II lymph nodes and radiation-induced xerostomia","volume":"58","author":"Astreinidou","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R10-20260109","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.ijrobp.2009.10.018","article-title":"Value of intensity-modulated radiotherapy in stage IV head-and-neck squamous cell carcinoma","volume":"78","author":"Dirix","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R11-20260109","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ijrobp.2006.06.040","article-title":"A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma","volume":"66","author":"Lee","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-20260109","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.oraloncology.2008.07.002","article-title":"Comparison between conventional and intensity-modulated post-operative radiotherapy for stage III and IV oral cavity cancer in terms of treatment results and toxicity","volume":"45","author":"Chen","year":"2009","journal-title":"Oral Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363817-201814060-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:58:42Z","timestamp":1786647522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01363817-201814060-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_362_16","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}